Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Center for the Prevention and Treatment of Visual Loss

Menu
Menu
Quick Links
Veterans Crisis Line Badge
My healthevet badge
 

Research Projects

VA Funded

VA Center for the Prevention and Treatment of Visual Loss
Randy Kardon, MD, Director
July 2009 - June 2019

Therapy of Nocturnal Intraocular Pressure Elevation Causing Glaucoma Progression
Michael Anderson, PhD, Co-Principal Investigator and Markus Kuehn, PhD, Co-Principal Investigator
January 2015 - December 2018

Mechanisms of neuronal dysfunction in mild Traumatic Brain Injury
Laura Dutca, PhD, Principal Investigator
August 2016 - July 2021

Automated Assessment of Optic Nerve Edema with Low-Cost Imaging
Mona Garvin, PhD, Principal Investigator
April 2016 - March 2020

CaMKII as a regulator of diabetic retinopathy
Isabella Grumbach, MD, PhD, Principal Investigator
January 2015 - December 2016

Chronic Effects of Blast Injury: Analyses of Alzheimer Related Pathology
Matthew Harper, PhD, Co-Principal Investigator
January 2014 - December 2018

CENC-Visual Sensory Impairments and Progession Following Mild Traumatic Bain Injury
Randy Kardon, MD, PhD, Principal Investigator
January 2016 - December 2018

New! Bioassay to Predict the Development and Progression of Glaucoma
Markus Kuehn, PhD, Principal Investigator
July 2018 - June 2022

Stem Cell Therapy for Glaucoma
Markus Kuehn, PhD, Principal Investigator
July 2014 - March 2018

 Photosensitivity as a preclinical assessment for treatment of post-traumatic headache
Andrew Russo, PhD, Co-Principal Investigator and Andrew Pieper, MD, PhD, Co-Principal Investigator
February 2016 - January 2020

Identification and treatment of brain regions causing post-traumatic headache
Levi Sowers, PhD, Principal Investigator
January 2016 - December 2020

Diabetic Neuropathy: Function-Structure of corneal nerves to assess injury-repair
Mark Yorek, PhD, Principal Investigator
January 2013 - December 2016

Testing the Peripheral Visual Field- Obtaining the Full View
Michael Wall, MD, Principal Investigator
October 2015 - September 2019

Calmodulin kinase II inhibition as novel molecular treatment of hypertension
Isabella Grumbach, MD, PhD, Principal Investigator
July 2013 - June 2017

Federal, Non-VA Funded

Three Dimensional Structure-Function Relationships in Glaucoma from SD-OCT
Michael Abramoff, MD, PhD, Principal Investigator
April 2008 - November 2016

Genetic Dissection of Pigmentary Glaucoma
Michael Anderson, PhD, Principal Investigator
February 2014 - January 2018

Molecular Genetics of Normal Tension Glaucoma
Michael Anderson, PhD, Principal Investigator
April 2014 - March 2018

3D Image Analysis approach to determine severity and cause of optic nerve edema
Mona Garvin, PhD, Principal Investigator
May 2013 - April 2018

Prevention and Treatment of TBI-Mediated visual and Brain Damage Using a Novel Protective Compound
Matthew Harper, PhD, Co-Principal Investigator
October 2014 - October 2017

Use of Photo-Electromyogram to Objectively Diagnose and Monitor Treatment of Post-TBI Light Sensitivity
Randy Kardon, MD, PhD, Principal Investigator
September 2011 - September 2016

New! Effect of exogenous fatty acids on diabetes neural/neurovascular complications
Mark Yorek, PhD, Principal Investigator
December 2015 - November 2019

CaMKII regulates key mechanisms of vascular response to injury in vivo
Isabella Grumbach, MD, PhD, Principal Investigator
April 2012 - March 2017

Foundation Funded

Audrey and LaVern Busse Neuro-Ophthalmology Research Fund
Randy Kardon, MD, PhD, Principal Investigator
2015 - 2016

Eye Fixation Stability for Evaluating Alzheimer Disease using OCT-based Quantification of Retinal Movements
Randy Kardon, MD, PhD, Principal Investigator
2015 - 2016

Commerically Funded

New! Effect of LCZ696 on Diabetic Vascular and Neural Complications
Mark Yorek, PhD, Principal Investigator
November 2015 - November 2017

Training Programs

 

Previously Funded

Cholinergic Drugs for Reversal of Visual Deficits in Glaucoma
Randy Kardon, MD, PhD, Principal Investigator
October 2010 - September 2014

Early Detection of Glaucoma Using Raman Spectroscopy
Matthew Harper, PhD, Principal Investigator
January 2012 - December 2013

Prevention of Hemorrhage and Death after Traumatic Blast Injury (TBI)
Randy Kardon, MD, PhD, Principal Investigator
October 2010 - September 2014

Improved Assessment of Visual Field Change
Michael Wall, MD, Principal Investigator
July 2010 - June 2014

Characterization of a Novel Model of Traumatic Brain Injury
Matthew Harper, PhD, Principal Investigator
October 2010 - September 2013

Computer Aided Detection of Diabetic Retinopathy in Veterans with Disabilities
Michael Abramoff, MD, PhD, Principal Investigator
January 2011 - December 2013

Genetics of Quantitative Traits Associated with Glaucoma
Michael Anderson, PhD, Co-Investigator
July 2009 - June 2014

Prevention of Diabetic Neuropathy with ACE Inhibitors
Mark Yorek, PhD, Princpal Investigator
September 2008 - May 2014

Diagnosis and Treatment Assessment of Diabetic Peripheral Neuropathy in Humans by Relating Confocal Microscopy of Corneal Nerves to Corneal Sensation
Randy Kardon, MD, PhD, Principal Investigator
2012-2013

Anti-CGRP Therapeutics
Andrew Russo, PhD, Principal Investigator
January 2011 - June 2013

Cyropreservation of mouse lines
Michael Anderson, PhD, Principal Investigator
2012 - 2014

Improved Assessment of Visual Field Change
Michael Wall, MD, Principal Investigator
July 2010 - December 2014

Retinal Vessel Measurements as Clinically Useful Predictors in Veterans
Michael Abramoff, MD, PhD, Principal Investigator
April 2013 - March 2015

Glaucoma Assessment Using a Mulitmodality Image Analysis Approach
Mona Garvin, PhD, Principal Investigator
April 2012 - March 2015

Insulin Resistance and Vascular Complications in Obesity and Type 2 Diabetes
Mark Yorek, PhD, Principal Investigator
April 2012 - March 2016

Retrospective Retinal Therapy Guided by 3D OCT Image Analysis
Michael Abramoff, Md, PhD, Principal Investigator
May 2010 - April 2016

NORDIC IIHTT Papiledema Evaluation by New Methods of Analyzing OCT
Mona Garvin, PhD, Principal Investigator
February 2012 - January 2016

Objective Methods to Test Visual Dysfunction in the Presence of Cognitive Impairment
Randy Kardon, MD, PhD, Principal Investigator
September 2010 - September 2015

Unfolded Protein Response in Glaucoma Pathogenesis
Markus Kuehn, PhD, Principal Investigator
September 2012 - August 2015

Peroxynitrite, Protein Nitration and Advanced Diabetic Neuropathy
Mark Yorek, PhD, Principal Investigator
February 2013 - March 2015

Longitudinal Idiopathic Intracranial Hypertension Treatment Trial
Michael Wall, MD, Principal Investigator
February 2009 - January 2016

CGRP-induced light aversion in a preclinical migraine model
Andrew Russo, PhD, Principal Investigator
June 2011 - May 2016

Rehabilatation of Diabetic Neuropathy and Retinopathy with P7C3-S243
Mark Yorek, PhD, Principal Investigator
November 2014 - October 2015

Development of Mouse Models for Dissecting LOXL1-Mediated Pathology
Michael Anderson, PhD, Principal Investigator
May 2014 - April 2016

Arnold and Mabel Beckman Initiative for Macular Research
Michael Abramoff, MD, PhD, Principal Investigator
July 2013 - June 2015

A 3 Year, Multi-Center Study to Evaluate Optical Coherence Tomography (OCT) as an Outcome Measure in Patients with Multiple Sclerosis
Randy Kardon, MD, PhD, Principal Investigator
June 2011 - April 2016